Hypertrophic cardiomyopathy: A complex disease.

Main|Search|PHGKB



Credit: Zhen Ma, University of California, Berkeley




Last Posted: Dec 06, 2018

---

• FDA takes new action to advance the development of reliable and beneficial genetic tests that can improve patient care
  FDA Press Release, December 4, 2018
• Hypertrophic cardiomyopathy: A complex disease.
  Young Laura et al. Cleveland Clinic journal of medicine 2018 May 85(5) 399-411
• A targeted next-generation gene panel reveals a novel heterozygous nonsense variant in TP63 gene in Arrhythmogenic Cardiomyopathy patients.
  Poloni Giulia et al. Heart rhythm 2018 Nov
• Arrhythmogenic Cardiomyopathy in 2018: ARVC/ALVC or Both?
  Bennett Richard G et al. Heart, lung & circulation 2018 Oct
• Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations.
  Domínguez Fernando et al. Journal of the American College of Cardiology 2018 Nov 72(20) 2471-2481
• Genetic Testing and Counseling for Hypertrophic Cardiomyopathy.
  Cirino Allison L et al. Cardiology clinics 2019 Feb 37(1) 35-43
• The Clinical Course of a Genetic Dilated Cardiomyopathy: Letting the Cat Out of the BAG3.
  Shaw Robin M et al. Journal of the American College of Cardiology 2018 Nov 72(20) 2482-2484
• Hypertrophic Cardiomyopathy Without Ventricular Hypertrophy: Usefulness of Genetic and Pathological Study in Preventing Sudden Death.
  Segura-Villalobos Federico et al. Revista espanola de cardiologia (English ed.) 2017 Jul 70(7) 604-606
• Modeling Hypertrophic Cardiomyopathy in a Dish
  NIH Director's Blog, November 8, 2018
• The genetics of hypertrophic cardiomyopathy.
  Akhtar Mohammed et al. Global cardiology science & practice 2018 Aug 2018(3) 36

more